Funded Biotechnology Startups in Australia
Disclosed round sizes in this Australia biotech slice show a clear outlier: Telix Pharmaceuticals’ 2024-07-23 round is disclosed at $431M, dwarfing the res…
Disclosed round sizes in this Australia biotech slice show a clear outlier: Telix Pharmaceuticals’ 2024-07-23 round is disclosed at $431M, dwarfing the rest of the largest disclosed amounts (e.g., Opthea at $114M on 2024-06-12, Propanc at $100M on 2025-10-15, and Mesoblast at $75M on 2025-12-30). Another size edge is how many “small” disclosed rounds cluster near the lower end: several Seed/early rounds sit at or below $300K–$2M (e.g., Clinials at $100K on 2022-03-21; Aravax’s $20M is far above that, while Lixa/Evrima Technologies/Tiny Bright Things each show $2M figures in 2022). Timing is also clustered: in the most recent window, 2026 rounds run from 2026-03-06 to 2026-03-24 (Cauldron Ferm $13M on 2026-03-24; HydGene Renewables $1M and SWAN Genomics $320K on 2026-03-06), while the oldest entry shown is BARD1 Life Sciences on 2021-07-23 ($11M). Stage and disclosure skew early-to-mid on paper: 10 of 50 rows are labeled “Series Unknown” and 1 of 50 is “undisclosed,” with “Series Unknown” appearing repeatedly across 2024–2025 (e.g., SWAN Genomics $320K on 2026-03-06 and Immutep $60M on 2024-06-05).
Most recent rounds
50 shownRelated listings
Frequently asked
What stands out as the largest disclosed round in this Australia biotech list, and how does it compare to the next-highest disclosed amounts?
Telix Pharmaceuticals has the largest disclosed amount at $431M on 2024-07-23, far above the next-largest disclosed figures shown, including Opthea at $114M (2024-06-12) and Propanc at $100M (2025-10-15). The $75M Mesoblast round (2025-12-30) and $60M Immutep round (2024-06-05) still sit well below Telix’s disclosed peak.
Do the rounds cluster tightly in time, especially near the top of the recency window?
Yes. The most recent year-end-to-early-2026 block is concentrated in March 2026: HydGene Renewables ($1M) and SWAN Genomics ($320K) are both dated 2026-03-06, and Cauldron Ferm is dated 2026-03-24 at $13M. Earlier years are less compressed, with the oldest row shown dating to 2021-07-23 (BARD1 Life Sciences, $11M).
Which disclosure labels dominate, and are “Series Unknown” or “undisclosed” rounds concentrated in particular years?
“Series Unknown” appears in 10 of 50 rows, with multiple examples spanning 2024–2026 (e.g., HydGene Renewables $1M on 2026-03-06; Telix Pharmaceuticals $431M on 2024-07-23; Immutep $60M on 2024-06-05). There is 1 “undisclosed” amount entry (Cell Bauhaus, Pre-Seed, dated 2024-10-10), which is the only row where the disclosed amount is not provided.
Are there cities that repeat often enough to matter for go-to-market or local diligence?
Sydney, New South Wales appears repeatedly, including Cauldron Ferm is in Orange (not Sydney), but multiple Sydney-area entries do cluster: On 2025-12-02 Kazia Therapeutics is Hornsby (NSW), and 2025-04-13 AdvanCell is Sydney ($11M) alongside 2025-05-06 Levur in Sydney ($780K) and 2024-10-22 Atomo Diagnostics in Leichhardt ($2M). Melbourne also shows repeated presence across years (e.g., Mesoblast $75M on 2025-12-30; Ena Respiratory $22M on 2025-10-22; Opthea $114M on 2024-06-12).
What stage mix dominates, and where do early-stage and later-stage rounds show clear separation in disclosed amounts?
Early-stage labels show a wide low-to-mid range: Seed or Pre-Seed entries include Levur (Pre-Seed, $780K on 2025-05-06), Tiny Bright Things (Seed, $2M on 2022-11-03), and Clinials (Seed, $100K on 2022-03-21). Later disclosed rounds include much higher amounts such as Ena Respiratory at $22M (Series B, 2025-10-22), Aravax at $20M (Series B, 2022-12-20), and Vaxxas at $23M (Series C, 2022-12-05), while several very large biotech rounds are still tagged “Series Unknown” (e.g., Telix Pharmaceuticals $431M on 2024-07-23 and Opthea $114M on 2024-06-12).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.